Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee
Trial details
- Registry ID
- NCT03485157
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the KneeNCT03485157 | MDXG | Phase 2 | Completed | 2022-04-19Actual |
| Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee OsteoarthritisNCT05796765 | MDXG | Phase 2 | Terminated | 2023-12-15Actual |
| A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)NCT04042844 | BioRestorative Therapies | Phase 2 | Recruiting | 2026-12Estimated |
| Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainNCT06325566 | MESO | Phase 3 | Active not recruiting | 2027-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |